1. Home
  2. NOMA vs TELA Comparison

NOMA vs TELA Comparison

Compare NOMA & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NOMADAR Corp.

NOMA

NOMADAR Corp.

HOLD

Current Price

$1.57

Market Cap

30.2M

ML Signal

HOLD

Logo TELA Bio Inc.

TELA

TELA Bio Inc.

HOLD

Current Price

$1.08

Market Cap

31.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NOMA
TELA
Founded
2023
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Services-Misc. Amusement & Recreation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
30.2M
31.4M
IPO Year
2025
2019

Fundamental Metrics

Financial Performance
Metric
NOMA
TELA
Price
$1.57
$1.08
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $2.08
AVG Volume (30 Days)
16.9K
★ 163.5K
Earning Date
11-18-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 37.59
EPS
★ N/A
N/A
Revenue
$6,376.00
★ $80,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$9.24
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 15.84
52 Week Low
$1.31
$0.50
52 Week High
$10.00
$1.52

Technical Indicators

Market Signals
Indicator
NOMA
TELA
Relative Strength Index (RSI) 43.25 39.64
Support Level $1.40 $0.93
Resistance Level $2.09 $0.97
Average True Range (ATR) 0.23 0.12
MACD 0.02 -0.04
Stochastic Oscillator 6.75 2.72

Price Performance

Historical Comparison
NOMA
TELA

About NOMA NOMADAR Corp.

Nomadar Corp operates at the intersection of sports and technology, focusing on high-performance training programs and cultural exchange. The company aims to connect athletes, coaches, and fans through inventive technological solutions, enhancing sports development beyond physical borders. It offers services like the High Performance Training (HPT) program and promotes the legacy of iconic athletes. The Company generates revenue through its High Performance Training Program and events management at the JP Financial Stadium.

About TELA TELA Bio Inc.

TELA Bio Inc a commercial-stage medical technology company focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.

Share on Social Networks: